DG
MDT icon

Davidson & Garrard’s Medtronic MDT Stock Holding History

Davidson & Garrard’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,032
Closed -$244K – 178
2017
Q1 		$244K Buy
+3,032
New +$237K 0.06% 163
2016
Q4 		– Sell
-2,722
Closed -$235K – 173
2016
Q3 		$235K Sell
2,722
-53
-2% -$4.62K 0.06% 158
2016
Q2 		$241K Buy
+2,775
New +$224K 0.06% 164

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Davidson & Garrard's MDT Position: Q2 2017 in Review

Davidson & Garrard sold out of Medtronic (MDT) in Q2 2017, closing a stake of 3,032 shares — an estimated $244K sold.

Davidson & Garrard first reported a position in MDT in Q2 2016 and held it in 3 quarters. The position peaked at $244K in Q1 2017. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Davidson & Garrard reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
  • Davidson & Garrard sold 3,032 Medtronic shares in Q2 2017, an estimated $244K.
  • Davidson & Garrard first reported a position in Medtronic in Q2 2016 and held it in 3 quarters.
  • Davidson & Garrard's Medtronic position peaked at $244K in Q1 2017.
  • 1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Davidson & Garrard's 13F filing for Q2 2017, filed 8 Aug 2017.